Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc.
August 15, 2018 06:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that...
Depomed Announces Second-Quarter 2018 Financial Results
August 08, 2018 07:30 ET
|
Depomed, Inc.
-- Raises Full-Year Earnings and Adjusted EBITDA Guidance Range and Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Confirms Regulatory Plan to File for FDA Approval of...
Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, August 8, 2018
July 09, 2018 08:30 ET
|
Depomed, Inc.
LAKE FOREST, Ill., July 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second-quarter 2018 financial results on Wednesday, August 8, 2018, before the...
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 06, 2018 16:05 ET
|
Depomed, Inc.
LAKE FOREST, Ill., July 06, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced that effective July 3, 2018, the Company granted ten newly-hired employees a total of 512,439 restricted...
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 07, 2018 17:00 ET
|
Depomed, Inc.
LAKE FOREST, Ill., June 07, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced that the Company will grant Phillip B. Donenberg, the Company’s new Chief Financial Officer and Senior Vice...
Depomed Announces the Appointment of Phillip B. Donenberg as Chief Financial Officer
June 05, 2018 08:30 ET
|
Depomed, Inc.
LAKE FOREST, Ill., June 05, 2018 (GLOBE NEWSWIRE) -- Lake Forest, Illinois, June 5, 2018 - Depomed, Inc. (NASDAQ:DEPO) today announced that it has appointed Phillip B. Donenberg as Chief Financial...
Depomed Announces First-Quarter 2018 Financial Results
May 10, 2018 08:00 ET
|
Depomed, Inc.
- Company Confirms Previous 2018 Guidance for Neurology Franchise Net Sales and Non-GAAP Adjusted EBITDA - - Amends Existing Agreement for CAMBIA Line Extension – - Announces New Co-Promotion...
Depomed to Present at the UBS Global Healthcare Conference
May 07, 2018 08:00 ET
|
Depomed, Inc.
LAKE FOREST, Ill., May 07, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate at the 2018 UBS Global Healthcare Conference in a...
Depomed to Report First-Quarter 2018 Financial Results on Thursday, May 10, 2018
May 03, 2018 08:00 ET
|
Depomed, Inc.
LAKE FOREST, Ill., May 03, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first-quarter 2018 financial results on Thursday, May 10, 2018, before the open...
Depomed Announces the Appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications
April 17, 2018 16:05 ET
|
Depomed, Inc.
NEWARK, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate...